GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ISL1 | hg19_v2_chr5_+_50678921_50678921 | -0.08 | 2.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_175711133 Show fit | 36.26 |
ENST00000409597.1
ENST00000413882.1 |
chimerin 1 |
|
chr4_-_176923483 Show fit | 18.37 |
ENST00000280187.7
ENST00000512509.1 |
glycoprotein M6A |
|
chr12_-_50290839 Show fit | 15.57 |
ENST00000552863.1
|
Fas apoptotic inhibitory molecule 2 |
|
chr4_-_186877806 Show fit | 13.06 |
ENST00000355634.5
|
sorbin and SH3 domain containing 2 |
|
chr14_-_60337684 Show fit | 12.33 |
ENST00000267484.5
|
reticulon 1 |
|
chr8_+_26371763 Show fit | 12.28 |
ENST00000521913.1
|
dihydropyrimidinase-like 2 |
|
chr1_-_95391315 Show fit | 11.81 |
ENST00000545882.1
ENST00000415017.1 |
calponin 3, acidic |
|
chr2_-_224467093 Show fit | 11.22 |
ENST00000305409.2
|
secretogranin II |
|
chrX_-_92928557 Show fit | 11.14 |
ENST00000373079.3
ENST00000475430.2 |
nucleosome assembly protein 1-like 3 |
|
chr5_+_140772381 Show fit | 10.45 |
ENST00000398604.2
|
protocadherin gamma subfamily A, 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 36.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 23.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 21.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 18.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 18.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
1.0 | 15.6 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 15.1 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.1 | 15.0 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 14.1 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 11.9 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 38.7 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 18.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 18.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.7 | 12.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 11.6 | GO:0043197 | dendritic spine(GO:0043197) |
0.6 | 11.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 11.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.5 | 9.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 9.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 9.7 | GO:0043005 | neuron projection(GO:0043005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 36.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.9 | 23.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 18.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.2 | 17.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 17.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 14.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 13.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 13.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 13.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
4.1 | 12.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 35.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 24.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 9.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 7.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 4.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 4.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 3.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 2.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 2.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.9 | PID RAS PATHWAY | Regulation of Ras family activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 35.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 12.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 10.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 9.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 9.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.3 | 8.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 8.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.3 | 5.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 3.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 3.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |